Osisko Metals Reports Preliminary Metallurgical Testwork Results From Gaspé Copper
MONTREAL, April 16, 2024 (GLOBE NEWSWIRE) — Osisko Metals Incorporated (the “Company” or “Osisko Metals“) (TSX-V: OM; OTCQX: OMZNF; FRANKFURT: […]
Standard Uranium Reports on Recent Exploration Insights at the Sun Dog Project with Option Partner Aero Energy Ltd.
VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) — Standard Uranium Ltd. (“Standard Uranium” or the “Company”) (TSX-V: STND) (OTCQB: […]
Southern California Clinic Signs Multi-Year Deal for MedMatrix AI Platform
VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) — MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:Y30) […]
Truth Social to Launch Streaming Platform
SARASOTA, Fla., April 16, 2024 (GLOBE NEWSWIRE) — Trump Media & Technology Group Corp. (NASDAQ:DJT) (“TMTG” or the “Company”), operator […]
TC Energy to issue first quarter 2024 results on May 3 and hold annual and special meeting of common shareholders on June 4
CALGARY, Alberta, April 16, 2024 (GLOBE NEWSWIRE) — TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) will […]
SAB Biotherapeutics Provides SAB-142 Trial Update
MIAMI BEACH, Fla., April 16, 2024 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB” or the “Company”), a clinical-stage biopharmaceutical […]
St. Michael’s Hospital Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
TORONTO, April 16, 2024 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), […]
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
ALPHARETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies […]
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
Nadia K. Waheed, MD, MPH, Appointed Chief Medical Officer; Peter K. Kaiser, MD, to Become Chief Development Officer; Andrea Gibson, PhD, […]
Company Provides 2024 Results of Operations
Company Generates $29.2 Million in Sales on 9-Month Transition Year Fort Lauderdale, FL, April 16, 2024 (GLOBE NEWSWIRE) — The […]
